Covid-19 Vaccine: Draw up immunization strategy now itself, says Biocon Chief Kiran Mazumdar-Shaw

Published On 2020-07-21 09:13 GMT   |   Update On 2024-02-14 10:27 GMT

Bengaluru: India needs to draw up its immunization strategy now itself on the administration of the vaccine for COVID-19 on the population when it comes out, says biotechnology industry veteran Kiran Mazumdar-Shaw.

"Vaccine is anybody's guess. Right from the end of this year to the middle of next year is the prediction", the Executive Chairperson of the city-headquartered biopharmaceuticals major Biocon said on the time-frame vis-a-vis its availability. She said some vaccine programs have just started phase 3 clinical trials, with phase 1 and phase 2 ones having shown mixed signals.

So, we are not sure, she said and, citing reports from the US, added: It looks like every vaccine needs two doses (per person). So, its not cheap", she told here in an interview.

"If the government can make sure that at least 20 percent of the most high-risk population is immunized, then we can sort of creating a control on the virus."

But Mazumdar-Shaw also noted 20 percent of the Indian population is a huge 200 to 300 million people. "Will the government bear it (cost)?", she asked. "So, one has to look at the pharmacoeconomics point of view and immunological rationale and find a balance between the two. Epidemiologists have to work out the model as to what is the minimum number of people who need to be vaccinated when the vaccine comes out. We cannot obviously vaccinate 1.3 billion people (the country's total population) in such a short time because there won't be enough vaccine", she said. Even if the vaccine producers were going to make a billion doses, it cannot be done in one month. "Maximum you can produce is 80 million to 100 million doses per month. So, which are the first 100 million people that will be vaccinated? Those are the kinds of planning we need to do now", she said.

Advertisement

"If the Bharat Biotech vaccine, or Zydus Cadila vaccine starts showing good, promising results, we could also have it (vaccine) by the end of the year", Mazumdar-Shaw said.

On when she expected coronavirus cases to peak in the country, she said there were various forecasts and projections, and each part of the country was at a different level.

"They (forecasts and projections) are basically saying in the next two-and-half-months to four months, various parts of the country should be peaking. By the end of the year, all parts of the country would have peaked. "

"By early December, we should have crossed the peak across the country. Every part of the country will peak at a different time, she said.

Mazumdar-Shaw hastened to add: And then people don't know about the next wave. That is another worry.

As on Monday morning, the country's COVID-19 cases tally stands at 11,18,043 and the death toll reached 27,497.

Read also: Biocon Itolizumab gets DCGI nod to treat COVID-19 patients

Tags:    
Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News